PRESTO: A phase III, open-label study of intensification of androgen blockade in patients with high-risk biochemically relapsed castration-sensitive prostate cancer (AFT-19) Journal Article


Authors: Aggarwal, R.; Heller, G.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T.; Appleman, L.; Weckstein, D.; Patnaik, A.; Bryce, A.; Shevrin, D.; Mohler, J.; Anderson, D.; Rao, A, ; Tagawa, S.; Tan, A.; Halabi, S.; Dooley, K.; O'Brien, P.; Chen, R.; Ryan, C. J.; Eggener, S. E.; Morris, M. J.; on behalf of the PRESTO Study Investigators
Article Title: PRESTO: A phase III, open-label study of intensification of androgen blockade in patients with high-risk biochemically relapsed castration-sensitive prostate cancer (AFT-19)
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 10
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-04-01
Start Page: 1114
End Page: 1123
Language: English
DOI: 10.1200/jco.23.01157
PROVIDER: EBSCOhost
PROVIDER: cinahl plus with full text
PUBMED: 38261983
PMCID: PMC11637124
DOI/URL:
Notes: Accession Number: 176268662 -- Entry Date: In Process -- Revision Date: 20240329 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: CINAHL Plus with Full Text
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Glenn Heller
    399 Heller
  2. Han Xiao
    59 Xiao
  3. Michael Morris
    577 Morris